News - anamorelin

Filter

Current filters:

anamorelin

Popular Filters

Chugai unit seals deal for Helsinn’s anamorelin in top EU markets

12-11-2013

Privately-held Swiss pharmaceutical group Helsinn has granted Chugai Pharma Marketing, a wholly-owned…

anamorelinChugai PharmaceuticalEuropeHelsinnLicensingOncologyPharmaceuticalRoche

Helsinn grants anamorelin rights to Stendhal for Latin American countries

29-01-2013

Privately-held Swiss pharmaceutical group Helsinn has granted Latin American specialty company Stendhal…

anamorelinHelsinnLicensingMetabolicsOncologyPharmaceuticalSouth AmericaStendhal

Helsinn moving forward with supportive cancer care products anamorelin and netupitant + palonosetron

26-09-2011

Privately-held, Switzerland-based Helsinn, focussed on the prevention of chemotherapy-induced nausea…

anamorelinEisaiHelsinnnetupitantOncologyPalonosetron hydrochloridePharmaceuticalResearch

Back to top